Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

Published Dec 20, 2019

Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

A new analysis shows that, among patients with metastatic non-squamous non-small cell lung cancer, the benefits of immunotherapy hold true regardless of the presence of a KRAS mutation.

NOW
PLAYING
Would You Buy These Potato Chips Instead of Another Snack Because They’re Pink? The Breast Cancer "Pinkwashing" Effect, Explained
NOW
PLAYING
Creativity & Help From Her Baby Girl Helped This Mom Stay 'Rock Solid' During Second Cancer, Leukemia
NOW
PLAYING
Cancer After 57 Days at Ground Zero: A Retired Firefighter Shares His 9/11 Story
NOW
PLAYING
Chemo During COVID-19: Survivors' Stories and Tips, Plus How Families Can Help
NOW
PLAYING
Continue Cancer Screenings Through COVID-19
NOW
PLAYING
The EEE-Mosquito Virus Is Coming - Should People With Cancer Be Worried? How To Protect Yourself
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.